How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Medical Analysis Systems, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
107 clearance records and 0 recall records in the covered releases, across 1 source company names and 38 product codes. Dated history runs from Feb 7, 1978 to Nov 5, 2004.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| MAS, DADE AND LIQUID ASSAYED DIABETES CONTROLK042717 · JJX | Medical Analysis Systems, Inc. | 510(k) | Nov 5, 2004FDA decision date |
| ABBOTT ARCHITECT STAT TROPONIN I LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL L, M AND HK041194 · JJX | Medical Analysis Systems, Inc. | 510(k) | Aug 16, 2004FDA decision date |
| MAS CARDIOIMMUNE TL LIQUID ASSAYED CARDIAC MARKER CONTROL, LEVELS 1,2 AND 3K040880 · JJY | Medical Analysis Systems, Inc. | 510(k) | Apr 28, 2004FDA decision date |
| MAS PAR TDMK032826 · DIF | Medical Analysis Systems, Inc. | 510(k) | Oct 9, 2003FDA decision date |
| MAS CARDIOIMMUNE PROBNP, MAS CARDIOIMMUNE TLK032335 · JJY | Medical Analysis Systems, Inc. | 510(k) | Aug 19, 2003FDA decision date |
| MAS BILIRUBIN LIQUID ASSAYED BILIRUBIN CONTROLK031890 · JJX | Medical Analysis Systems, Inc. | 510(k) | Jul 16, 2003FDA decision date |
| MAS TOX AMMONIA CONTROLLIQUID ASSAYED TOX AMMONIA CONTROLK031392 · DKC | Medical Analysis Systems, Inc. | 510(k) | Jul 1, 2003FDA decision date |
| URICHEMTRAK LIQUID ASSAYED URINE CONTROLK031441 · JJW | Medical Analysis Systems, Inc. | 510(k) | Jul 1, 2003FDA decision date |
| MAS CARDIOLMMUNE PROBNP LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL 1, 2 AND 3K031364 · JJY | Medical Analysis Systems, Inc. | 510(k) | May 30, 2003FDA decision date |
| MAS CHEMTRAK H & DADE MONI-TROL H LIQUID ASSAYED CHEMISTRY CONTROLK030942 · JJY | Medical Analysis Systems, Inc. | 510(k) | Apr 28, 2003FDA decision date |
| MAS LIPID LEVEL 1 AND 2K030679 · JJY | Medical Analysis Systems, Inc. | 510(k) | Mar 14, 2003FDA decision date |
| MAS CARDIOIMMUNE TL LOW LEVEL LIQUID ASSAYED CARDIAC MARKER CONTROL, DADE CARDIAC TL LOW LEVEL LIQUID ASSAYED CARDIAC MAK023669 · JJY | Medical Analysis Systems, Inc. | 510(k) | Dec 19, 2002FDA decision date |
| MAS T-MARKER, LEVEL 1,2 AND 3, DADE SPECIAL-T MARKER, LEVEL 1,2 AND 3K023867 · JJY | Medical Analysis Systems, Inc. | 510(k) | Dec 17, 2002FDA decision date |
| MAS UA CONTROL LIQUID ASSAYED URINALYSIS CONTROL, DADE ASSAYED URINALYSIS CONTROLK023928 · JJW | Medical Analysis Systems, Inc. | 510(k) | Dec 11, 2002FDA decision date |
| MAS DIABETES CONTROL - LYOPHILIZED ASSAYED DIABETES CONTROLK023307 · JJX | Medical Analysis Systems, Inc. | 510(k) | Oct 31, 2002FDA decision date |
| MAS UA CONTROL, DADE UA CONTROL- LIQUID ASSAYED URINALYSIS CONTROLK021155 · JJW | Medical Analysis Systems, Inc. | 510(k) | Apr 29, 2002FDA decision date |
| MODIFICATION TO MAS CARDIOLMMUNE TL; DADE CARDIAC TLK013995 · JJY | Medical Analysis Systems, Inc. | 510(k) | Dec 21, 2001FDA decision date |
| MAS LIPID CONTROL, LIQUID ASSAYED LIPID CONTROL, LEVEL 1 AND 2, DADE LIPID CONTROL, LIQUID ASSAYED LIPID CONTROL, LEVELK013734 · JJY | Medical Analysis Systems, Inc. | 510(k) | Dec 7, 2001FDA decision date |
| TRI-POINT LIQUIMMUNE LIQUID ASSAYED CONTROL LEVELS 1,2, AND 3K011731 · JJY | Medical Analysis Systems, Inc. | 510(k) | Jul 5, 2001FDA decision date |
| CHEMTRAK PLATINUM COMPREHENSIVE LIQUID ASSAYED CHEMISTRY AND TDM CONTROL LEVELS 1, 2, 3K011548 · JJY | Medical Analysis Systems, Inc. | 510(k) | Jun 18, 2001FDA decision date |
| CARDIOIMMUNE TL CARDIAC MARKER CONTROL LEVELS 1, 2, 3, AND MULTI-PACKK010111 · JJY | Medical Analysis Systems, Inc. | 510(k) | Feb 28, 2001FDA decision date |
| DADE TRU-LIQUID MONI-TROL CHEMISTRY CONTROL LEVELS 1, MID, 2, AND S (ASSAYED)K001758 · JJY | Medical Analysis Systems, Inc. | 510(k) | Jul 5, 2000FDA decision date |
| TRI-POINT, LIQUIMMUNE LIQUID ASSAYED IMMUNOASSAY CONTROL, LEVELS 1, 2, AND 3K993546 · JJY | Medical Analysis Systems, Inc. | 510(k) | Nov 30, 1999FDA decision date |
| CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3K992829 · GGN | Medical Analysis Systems, Inc. | 510(k) | Nov 22, 1999FDA decision date |
| CARDIOIMMUNE CARDIAC MARKER CONTROL LEVELS 1,2, AND 3K992430 · JJT | Medical Analysis Systems, Inc. | 510(k) | Aug 30, 1999FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.